A Dose Finding Pharmacokinetic Study of the Tumour-targeting Human L19IL2 Monoclonal Antibody-Cytokine Fusion Protein in Patients With Advanced Solid Tumours

This study has been completed.
INC Research
Information provided by (Responsible Party):
Philogen S.p.A.
ClinicalTrials.gov Identifier:
First received: January 27, 2010
Last updated: February 24, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2009
  Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)
No publications provided by Philogen S.p.A.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):